GlassScriptPhysician profile
Robert Joseph Cabry
NPI 1326093352
$2,112.81
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,842 · 2020: $159 · 2023: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $723.42 | 2019-2020 | |
| Amgen INC. | $286.27 | 2019 | |
| Pacira Therapeutics, INC. | $252.77 | 2019-2020 | |
| Pfizer INC. | $124.98 | 2019 | |
| Janssen Biotech, INC. | $111.70 | 2023 | Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.52 | 2019-2020 | |
| Depuy Synthes Sales INC. | $81.79 | 2019-2020 | |
| Si-Bone, INC. | $72.08 | 2019 | |
| Collegium Pharmaceutical, INC. | $46.82 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $41.25 | 2019 | |
| Arteriocyte Medical Systems, INC. | $34.83 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.60 | 2019 | |
| Electronic Waveform Lab, INC. | $31.68 | 2019 | |
| Wright Medical Technology, INC. | $28.00 | 2019 | |
| Arbor Pharmaceuticals, INC. | $27.03 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $23.35 | 2019 | |
| Daiichi Sankyo INC. | $14.82 | 2019 | |
| Forte Bio-Pharma LLC | $14.41 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.02 | 2019 | |
| Sentynl Therapeutics, INC. | $13.10 | 2019 | |
| Biodelivery Sciences International, INC. | $12.63 | 2019 | |
| Shionogi INC | $12.15 | 2019 | |
| Assertio Therapeutics, INC. | $12.07 | 2019 | |
| Zyla Life Sciences, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cabry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.